Cyclerion Therapeutics, Inc. Common Stock
CYCN XNAS
$4.13
-0.36 (-8.69%)
▼
15-min delayed
Open
$4.05
High
$4.30
Low
$4.05
Volume
14.6K
Market Cap
$19.29M
About Cyclerion Therapeutics, Inc. Common Stock
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $0 | $-1,755,000 | $-0.41 |
| Q1 2026 | $0 | $-3,177,000 | $-0.76 |
| FY 2025 | $2.07M | $-3,528,000 | $-1.11 |
| Q3 2025 | $875.0K | $-976,000 | $-0.30 |
Earnings & Analyst Ratings
Next Earnings:
Tue, Nov 10, 2026
Calendar →
TickerDaily Coverage
Stock Market Today, April 3, 2026: Weekly Recap of Explosive Penny Stock Moves
Market News
David Brooks · Apr 3, 2026
Friday, April 3, 2026 marked the close of a volatile week dominated by biotech and micro-cap...
Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 320.3% Today?
Market News
Alex Chen · Apr 1, 2026
Cyclerion Therapeutics (CYCN) exploded higher Wednesday, gaining 320.3% to $6.49 on unprecedented...
Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 253.5% Today?
Penny Stocks
Marcus Rivera · Apr 1, 2026
Cyclerion Therapeutics (CYCN) exploded 253.5% Wednesday, April 1, 2026, closing at $5.43 after...
View All Coverage →
Get CYCN Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Cyclerion Therapeutics, Inc. Common Stock.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.